Latest filing published 04 Aug 2026 for Imunon, Inc., €9,572. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Frederick J. Fritz, listed as board member, appears in our data through filings on Imunon, Inc. shares, published by SEC (Form 4). Between 2 February 2016 and 31 July 2026, the trades on record add up to 7 filings.
Every open-market trade on record is a purchase: 3 purchases worth €42k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 share grants.
In size, the median ticket on the buying side is €15k. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
Most recently, on 4 August 2026, the filings show a share grant worth €9,572 in Imunon, Inc. The last purchase on record was published on 11 April 2022, which is 1,651 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations